7-12337224-T-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001135924.3(VWDE):āc.4415A>Cā(p.Asn1472Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000709 in 1,551,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000066 ( 0 hom., cov: 33)
Exomes š: 0.0000071 ( 0 hom. )
Consequence
VWDE
NM_001135924.3 missense
NM_001135924.3 missense
Scores
1
8
10
Clinical Significance
Conservation
PhyloP100: 5.78
Genes affected
VWDE (HGNC:21897): (von Willebrand factor D and EGF domains) Predicted to enable signaling receptor binding activity. Predicted to be involved in anatomical structure development. Predicted to be active in cell surface and extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.30679232).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VWDE | NM_001135924.3 | c.4415A>C | p.Asn1472Thr | missense_variant | 25/29 | ENST00000275358.8 | NP_001129396.1 | |
VWDE | NM_001346972.2 | c.4070A>C | p.Asn1357Thr | missense_variant | 23/27 | NP_001333901.1 | ||
VWDE | NM_001346973.2 | c.3605A>C | p.Asn1202Thr | missense_variant | 23/27 | NP_001333902.1 | ||
VWDE | NR_144534.2 | n.5237A>C | non_coding_transcript_exon_variant | 26/30 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VWDE | ENST00000275358.8 | c.4415A>C | p.Asn1472Thr | missense_variant | 25/29 | 5 | NM_001135924.3 | ENSP00000275358 | P1 | |
VWDE | ENST00000452576.6 | c.*1179A>C | 3_prime_UTR_variant, NMD_transcript_variant | 26/30 | 1 | ENSP00000401687 | ||||
VWDE | ENST00000521169.5 | c.*2793A>C | 3_prime_UTR_variant, NMD_transcript_variant | 22/26 | 5 | ENSP00000428810 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152218Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
152218
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000127 AC: 2AN: 157770Hom.: 0 AF XY: 0.0000120 AC XY: 1AN XY: 83244
GnomAD3 exomes
AF:
AC:
2
AN:
157770
Hom.:
AF XY:
AC XY:
1
AN XY:
83244
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000714 AC: 10AN: 1399674Hom.: 0 Cov.: 34 AF XY: 0.00000724 AC XY: 5AN XY: 690328
GnomAD4 exome
AF:
AC:
10
AN:
1399674
Hom.:
Cov.:
34
AF XY:
AC XY:
5
AN XY:
690328
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74364
GnomAD4 genome
AF:
AC:
1
AN:
152218
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74364
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2022 | The c.4415A>C (p.N1472T) alteration is located in exon 25 (coding exon 25) of the VWDE gene. This alteration results from a A to C substitution at nucleotide position 4415, causing the asparagine (N) at amino acid position 1472 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.
REVEL
Benign
Sift
Uncertain
D;.
Sift4G
Uncertain
D;D
Polyphen
D;.
Vest4
MutPred
Gain of phosphorylation at N1472 (P = 0.0582);.;
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at